Peritoneal Dialysate Analysis Device, US12601733B2
Summary
USPTO granted patent US12601733B2 to AWAK TECHNOLOGIES PTE LTD on April 14, 2026, covering a device for analyzing spent peritoneal dialysate from a peritoneal dialysis apparatus. The device includes housings attachable to the dialysis apparatus, test components with reagents for detecting substances in the dialysate, and fluidic conduits for communicating dialysate to the test components. The patent contains 13 claims and was filed on June 28, 2021.
What changed
USPTO issued patent grant US12601733B2 to AWAK TECHNOLOGIES PTE LTD for a peritoneal dialysate analysis device. The patent covers housings attachable to a peritoneal dialysis apparatus, test components with reagents for detecting substances in dialysate, and fluidic conduits for transporting dialysate to the test components.
Medical device manufacturers in the dialysis space should consider the scope of this patent when developing or improving peritoneal dialysis analysis products. Competitors may need to design around this patent or seek licensing arrangements with AWAK TECHNOLOGIES.
What to do next
- Monitor for updates
Archived snapshot
Apr 15, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Devices for peritoneal dialysate analysis
Grant US12601733B2 Kind: B2 Apr 14, 2026
Assignee
AWAK TECHNOLOGIES PTE LTD
Inventors
Yue Wang, Peter Haywood, Suresha Belur Venkataraya, Mandar Manohar Gori
Abstract
The present disclosure generally relates to a device for analysing spent peritoneal dialysate from a peritoneal dialysis apparatus. The device comprises: a set of housings attachable to the peritoneal dialysis apparatus; a set of test components disposed in the housings, each test component and comprising one or more reagents for detecting one or more substances; and a set of fluidic conduits connected to the housings for communicating the dialysate from the peritoneal dialysis apparatus to the housings, wherein the test components are arranged for the reagents to react with the dialysate communicated to the housings and thereby detect the substances in the dialysate.
CPC Classifications
A61B 5/14532 A61B 5/14546 A61B 5/201 A61B 5/4848 A61B 5/6823 A61B 5/6866 A61M 1/1609 A61M 1/28 A61M 1/284 A61M 2205/18 A61M 2205/33 A61M 2205/3553 A61M 2205/3561 A61M 2205/3576 A61M 2205/584 G01N 33/50 G16H 10/40
Filing Date
2021-06-28
Application No.
18003205
Claims
13
Related changes
Get daily alerts for USPTO Patent Grants - Medical Devices (A61M)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Medical Devices (A61M) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.